Jessica E Haberer

InstitutionHarvard Medical School
AddressBoston
Massachusetts
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 2 Covid-19 publications, with a maximum of 1 publications in May 2021 and August 2021
    All Publications
    Bar chart showing 133 publications over 13 distinct years, with a maximum of 24 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Haberer JE, van der Straten A, Safren SA, Johnson MO, Amico KR, Del Rio C, Andrasik M, Wilson IB, Simoni JM. Individual health behaviours to combat the COVID-19 pandemic: lessons from HIV socio-behavioural science. J Int AIDS Soc. 2021 08; 24(8):e25771. PMID: 34339113.
      Citations:    Fields:    Translation:HumansPHPublic Health
    2. Fouda Mbarga N, Epee E, Mbarga M, Ouamba P, Nanda H, Nkengni A, Guekeme J, Eyong J, Tossoukpe S, Noumedem Sosso S, Ngono Ngono E, Ntsama LM, Bonyomo L, Tchatchoua P, Vogue N, Metomb S, Ale F, Ousman M, Job D, Moussi C, Tamakloe M, Haberer JE, Ndeso Atanga S, Halle-Ekane G, Boum Y. Clinical profile and factors associated with COVID-19 in Yaounde, Cameroon: A prospective cohort study. PLoS One. 2021; 16(5):e0251504. PMID: 33979402.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    3. Kaida A, Kabakyenga J, Bwana M, Bajunirwe F, Muyindike W, Bennett K, Kembabazi A, Haberer JE, Boum Y, Martin JN, Hunt PW, Bangsberg DR, Matthews LT. High Incidence of Intended Partner Pregnancy Among Men Living With HIV in Rural Uganda: Implications for Safer Conception Services. J Acquir Immune Defic Syndr. 2019 08 15; 81(5):497-507. PMID: 30973545.
      Citations: 2     Translation:Humans
    4. Mallayasamy S, Chaturvedula A, Fossler MJ, Sale ME, Hendrix CW, Haberer JE. Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling Approach. Front Pharmacol. 2019; 10:785. PMID: 31354496.
      Citations: 1     
    5. Ortblad KF, Kibuuka Musoke D, Ngabirano T, Nakitende A, Harling G, Haberer JE, McConnell M, Salomon JA, Oldenburg CE, Bärnighausen T. The Effect of HIV Self-Testing Delivery Models on Female Sex Workers' Sexual Behaviors: A Randomized Controlled Trial in Urban Uganda. AIDS Behav. 2019 May; 23(5):1225-1239. PMID: 30652205.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    6. Dworkin MS, Panchal P, Wiebel W, Garofalo R, Haberer JE, Jimenez A. A triaged real-time alert intervention to improve antiretroviral therapy adherence among young African American men who have sex with men living with HIV: focus group findings. BMC Public Health. 2019 Apr 11; 19(1):394. PMID: 30971243.
      Citations: 5     Fields:    Translation:HumansCells
    7. Zanoni BC, Sibaya T, Cairns C, Haberer JE. Barriers to Retention in Care are Overcome by Adolescent-Friendly Services for Adolescents Living with HIV in South Africa: A Qualitative Analysis. AIDS Behav. 2019 Apr; 23(4):957-965. PMID: 30535836.
      Citations: 16     Fields:    Translation:Humans
    8. Haberer JE, Mugo N, Baeten JM, Pyra M, Bukusi E, Bekker LG. PrEP as a Lifestyle and Investment for Adolescent Girls and Young Women in Sub-Saharan Africa. J Int Assoc Provid AIDS Care. 2019 Jan-Dec; 18:2325958219831011. PMID: 30776954.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    9. Zanoni BC, Elliott RJ, Neilan AM, Haberer JE. Screening for HIV and linkage to care in adolescents: insights from a systematic review of recent interventions in high- versus low- and middle-income settings. Adolesc Health Med Ther. 2018; 9:211-235. PMID: 30584383.
      Citations: 8     
    10. Meyer AJ, Babirye D, Armstrong-Hough M, Mark D, Ayakaka I, Katamba A, Haberer JE, Davis JL. Text Messages Sent to Household Tuberculosis Contacts in Kampala, Uganda: Process Evaluation. JMIR Mhealth Uhealth. 2018 Nov 20; 6(11):e10239. PMID: 30459147.
      Citations: 3     Fields:    
    11. Pyra M, Brown ER, Haberer JE, Heffron R, Celum C, Bukusi EA, Asiimwe S, Katabira E, Mugo NR, Baeten JM. Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships. AIDS Behav. 2018 Nov; 22(11):3718-3725. PMID: 30006791.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    12. Jarolimova J, Kabakyenga J, Bennett K, Muyindike W, Kembabazi A, Martin JN, Hunt PW, Boum Y, Haberer JE, Bangsberg DR, Kaida A, Matthews LT. Contraceptive use following unintended pregnancy among Ugandan women living with HIV. PLoS One. 2018; 13(10):e0206325. PMID: 30359430.
      Citations: 2     Fields:    Translation:Humans
    13. Campbell JI, Eyal N, Musiimenta A, Burns B, Natukunda S, Musinguzi N, Haberer JE. Ugandan Study Participants Experience Electronic Monitoring of Antiretroviral Therapy Adherence as Welcomed Pressure to Adhere. AIDS Behav. 2018 Oct; 22(10):3363-3372. PMID: 29926301.
      Citations: 6     Fields:    Translation:Humans
    14. Bell KM, Haberer JE. Actionable Adherence Monitoring: Technological Methods to Monitor and Support Adherence to Antiretroviral Therapy. Curr HIV/AIDS Rep. 2018 10; 15(5):388-396. PMID: 30232578.
      Citations: 6     Fields:    Translation:Humans
    15. Musinguzi N, Muwonge T, Ngure K, Katabira E, Mugo N, Burns BFO, Baeten JM, Heffron R, Haberer JE. Comparison of short messaging service self-reported adherence with other adherence measures in a demonstration project of HIV preexposure prophylaxis in Kenya and Uganda. AIDS. 2018 09 24; 32(15):2237-2245. PMID: 30005025.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    16. Young CR, Kaida A, Kabakyenga J, Muyindike W, Musinguzi N, Martin JN, Hunt PW, Bangsberg DR, Haberer JE, Matthews LT. Prevalence and correlates of physical and sexual intimate partner violence among women living with HIV in Uganda. PLoS One. 2018; 13(8):e0202992. PMID: 30148854.
      Citations: 5     Fields:    Translation:HumansCells
    17. Pyra M, Anderson PL, Hendrix CW, Heffron R, Mugwanya K, Haberer JE, Thomas KK, Celum C, Donnell D, Marzinke MA, Bukusi EA, Mugo NR, Asiimwe S, Katabira E, Baeten JM. Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis. AIDS. 2018 08 24; 32(13):1891-1898. PMID: 29894385.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    18. Boum Ii Y, Burns BF, Siedner M, Mburu Y, Bukusi E, Haberer JE. Advancing equitable global health research partnerships in Africa. BMJ Glob Health. 2018; 3(4):e000868. PMID: 30167335.
      Citations: 12     
    19. Chang JL, Lee SA, Tsai AC, Musinguzi N, Muzoora C, Bwana B, Boum Y, Haberer JE, Hunt PW, Martin J, Bangsberg DR, Kroetz DL, Siedner MJ. CYP2B6 Genetic Polymorphisms, Depression, and Viral Suppression in Adults Living with HIV Initiating Efavirenz-Containing Antiretroviral Therapy Regimens in Uganda: Pooled Analysis of Two Prospective Studies. AIDS Res Hum Retroviruses. 2018 11; 34(11):982-992. PMID: 29973058.
      Citations: 2     Fields:    Translation:HumansCells
    20. Muiru AN, Bibangambah P, Hemphill L, Sentongo R, Kim JH, Triant VA, Bangsberg DR, Tsai AC, Martin JN, Haberer JE, Boum Y, Plutzky J, Hunt PW, Okello S, Siedner MJ. Distribution and Performance of Cardiovascular Risk Scores in a Mixed Population of HIV-Infected and Community-Based HIV-Uninfected Individuals in Uganda. J Acquir Immune Defic Syndr. 2018 08 01; 78(4):458-464. PMID: 29652762.
      Citations: 8     Fields:    Translation:Humans
    21. McCluskey SM, Lee GQ, Kamelian K, Kembabazi A, Musinguzi N, Bwana MB, Muzoora C, Haberer JE, Hunt PW, Martin JN, Boum Y, Bangsberg DR, Harrigan PR, Siedner MJ. Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005-2013. AIDS Patient Care STDS. 2018 07; 32(7):257-264. PMID: 29985647.
      Citations: 4     Fields:    Translation:HumansCells
    22. Castillo-Mancilla JR, Morrow M, Boum Y, Byakwaga H, Haberer JE, Martin JN, Bangsberg D, Mawhinney S, Musinguzi N, Huang Y, Tracy RP, Burdo TH, Williams K, Muzzora C, Hunt PW, Siedner MJ. Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression. J Acquir Immune Defic Syndr. 2018 04 15; 77(5):507-513. PMID: 29346185.
      Citations: 10     Translation:HumansCells
    23. Mugyenyi AEK, Haberer JE, O'Neil I. Pleasure and practice: a qualitative study of the individual and social underpinnings of shisha use in cafes among youth in the UK. BMJ Open. 2018 04 13; 8(4):e018989. PMID: 29654007.
      Citations: 1     Fields:    Translation:Humans
    24. Abaasa A, Hendrix C, Gandhi M, Anderson P, Kamali A, Kibengo F, Sanders EJ, Mutua G, Bumpus NN, Priddy F, Haberer JE. Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value. AIDS Behav. 2018 04; 22(4):1165-1173. PMID: 29090394.
      Citations: 24     Fields:    Translation:HumansPHPublic Health
    25. Armstrong-Hough M, Ggita J, Ayakaka I, Dowdy D, Cattamanchi A, Haberer JE, Katamba A, Davis JL. Brief Report: "Give Me Some Time": Facilitators of and Barriers to Uptake of Home-Based HIV Testing During Household Contact Investigation for Tuberculosis in Kampala, Uganda. J Acquir Immune Defic Syndr. 2018 04 01; 77(4):400-404. PMID: 29300218.
      Citations: 4     Translation:HumansPHPublic Health
    26. Harris RA, Haberer JE, Musinguzi N, Chang KM, Schechter CB, Doubeni CA, Gross R. Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model. PLoS One. 2018; 13(3):e0194713. PMID: 29566096.
      Citations: 2     Fields:    Translation:HumansCells
    27. Lambert RF, Orrell C, Bangsberg DR, Haberer JE. Factors that Motivated Otherwise Healthy HIV-Positive Young Adults to Access HIV Testing and Treatment in South Africa. AIDS Behav. 2018 03; 22(3):733-741. PMID: 28190116.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    28. Castillo-Mancilla JR, Haberer JE. Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring. Curr HIV/AIDS Rep. 2018 02; 15(1):49-59. PMID: 29380227.
      Citations: 44     Fields:    Translation:HumansCellsPHPublic Health
    29. Pyra M, Haberer JE, Heffron R, Kidoguchi L, Brown ER, Bukusi EA, Asiimwe S, Celum C, Katabira E, Mugo NR, Baeten JM. Brief Report: PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships. J Acquir Immune Defic Syndr. 2018 01 01; 77(1):41-45. PMID: 29016523.
      Citations: 5     Translation:HumansPHPublic Health
    30. Zanoni BC, Sibaya T, Cairns C, Lammert S, Haberer JE. Higher retention and viral suppression with adolescent-focused HIV clinic in South Africa. PLoS One. 2017; 12(12):e0190260. PMID: 29287088.
      Citations: 26     Fields:    Translation:Humans
    31. Lambert RF, Orrell C, Haberer JE. "It was pain. That's it. It was pain." Lack of oral health care among otherwise healthy young adults living with HIV in South Africa: A qualitative study. PLoS One. 2017; 12(12):e0188353. PMID: 29272290.
      Citations: 2     Fields:    Translation:Humans
    32. Haberer JE, Ngure K, Muwonge T, Mugo N, Katabira E, Heffron R, Musinguzi N, Bangsberg DR, Celum C, Baeten JM. Brief Report: Context Matters: PrEP Adherence is Associated With Sexual Behavior Among HIV Serodiscordant Couples in East Africa. J Acquir Immune Defic Syndr. 2017 12 15; 76(5):488-492. PMID: 28961676.
      Citations: 9     Translation:HumansPHPublic Health
    33. Ortblad K, Kibuuka Musoke D, Ngabirano T, Nakitende A, Magoola J, Kayiira P, Taasi G, Barresi LG, Haberer JE, McConnell MA, Oldenburg CE, Bärnighausen T. Direct provision versus facility collection of HIV self-tests among female sex workers in Uganda: A cluster-randomized controlled health systems trial. PLoS Med. 2017 Nov; 14(11):e1002458. PMID: 29182634.
      Citations: 44     Fields:    Translation:HumansPHPublic Health
    34. Lee GQ, Bangsberg DR, Mo T, Lachowski C, Brumme CJ, Zhang W, Lima VD, Boum Y, Mwebesa BB, Muzoora C, Andia I, Mbalibulha Y, Kembabazi A, Carroll R, Siedner MJ, Haberer JE, Mocello AR, Kigozi SH, Hunt PW, Martin JN, Harrigan PR. Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by near-full-genome population and deep sequencing approaches. AIDS. 2017 11 13; 31(17):2345-2354. PMID: 28832407.
      Citations: 10     Fields:    Translation:HumansCells
    35. Armstrong-Hough M, Turimumahoro P, Meyer AJ, Ochom E, Babirye D, Ayakaka I, Mark D, Ggita J, Cattamanchi A, Dowdy D, Mugabe F, Fair E, Haberer JE, Katamba A, Davis JL. Drop-out from the tuberculosis contact investigation cascade in a routine public health setting in urban Uganda: A prospective, multi-center study. PLoS One. 2017; 12(11):e0187145. PMID: 29108007.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    36. Campbell JI, Aturinda I, Mwesigwa E, Burns B, Santorino D, Haberer JE, Bangsberg DR, Holden RJ, Ware NC, Siedner MJ. The Technology Acceptance Model for Resource-Limited Settings (TAM-RLS): A Novel Framework for Mobile Health Interventions Targeted to Low-Literacy End-Users in Resource-Limited Settings. AIDS Behav. 2017 Nov; 21(11):3129-3140. PMID: 28421356.
      Citations: 23     Fields:    Translation:Humans
    37. Linnemayr S, Huang H, Luoto J, Kambugu A, Thirumurthy H, Haberer JE, Wagner G, Mukasa B. Text Messaging for Improving Antiretroviral Therapy Adherence: No Effects After 1 Year in a Randomized Controlled Trial Among Adolescents and Young Adults. Am J Public Health. 2017 12; 107(12):1944-1950. PMID: 29048966.
      Citations: 31     Fields:    Translation:Humans
    38. McCluskey SM, Boum Y, Musinguzi N, Haberer JE, Martin JN, Hunt PW, Marconi VC, Bangsberg DR, Siedner MJ. Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure. J Acquir Immune Defic Syndr. 2017 10 01; 76(2):183-187. PMID: 28628529.
      Citations: 10     Translation:HumansCells
    39. Richardson HS, Eyal N, Campbell JI, Haberer JE. When Ancillary Care Clashes with Study Aims. N Engl J Med. 2017 Sep 28; 377(13):1213-1215. PMID: 28953445.
      Citations: 4     Fields:    Translation:Humans
    40. Matthews LT, Burns BF, Bajunirwe F, Kabakyenga J, Bwana M, Ng C, Kastner J, Kembabazi A, Sanyu N, Kusasira A, Haberer JE, Bangsberg DR, Kaida A. Beyond HIV-serodiscordance: Partnership communication dynamics that affect engagement in safer conception care. PLoS One. 2017; 12(9):e0183131. PMID: 28880892.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    41. Garrison LE, Haberer JE. Technological methods to measure adherence to antiretroviral therapy and preexposure prophylaxis. Curr Opin HIV AIDS. 2017 Sep; 12(5):467-474. PMID: 28590335.
      Citations: 17     Fields:    Translation:HumansPHPublic Health
    42. Velloza J, Celum C, Haberer JE, Ngure K, Irungu E, Mugo N, Baeten JM, Heffron R. Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda. AIDS Behav. 2017 Aug; 21(8):2509-2518. PMID: 28634661.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    43. Andriesen J, Bull S, Dietrich J, Haberer JE, Van Der Pol B, Voronin Y, Wall KM, Whalen C, Priddy F. Using Digital Technologies in Clinical HIV Research: Real-World Applications and Considerations for Future Work. J Med Internet Res. 2017 07 31; 19(7):e274. PMID: 28760729.
      Citations: 6     Fields:    Translation:Humans
    44. Haberer JE, Kidoguchi L, Heffron R, Mugo N, Bukusi E, Katabira E, Asiimwe S, Thomas KK, Celum C, Baeten JM. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence. J Int AIDS Soc. 2017 07 25; 20(1):21842. PMID: 28741331.
      Citations: 32     Fields:    Translation:HumansPHPublic Health
    45. Musinguzi N, Mocello RA, Boum Y, Hunt PW, Martin JN, Haberer JE, Bangsberg DR, Siedner MJ. Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda. AIDS Behav. 2017 Jun; 21(6):1735-1740. PMID: 27256394.
      Citations: 11     Fields:    Translation:Humans
    46. Thomson KA, Haberer JE, Marzinke MA, Mujugira A, Hendrix CW, Celum C, Ndase P, Ronald A, Bangsberg DR, Baeten JM. Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention. J Acquir Immune Defic Syndr. 2017 06 01; 75(2):184-189. PMID: 28291050.
      Citations: 1     Translation:HumansCellsPHPublic HealthCTClinical Trials
    47. North CM, Valeri L, Hunt PW, Mocello AR, Martin JN, Boum Y, Haberer JE, Bangsberg DR, Christiani DC, Siedner MJ. Cooking fuel and respiratory symptoms among people living with HIV in rural Uganda. ERJ Open Res. 2017 Apr; 3(2). PMID: 28534032.
      Citations: 6     
    48. Lee S, Byakwaga H, Boum Y, Burdo TH, Williams KC, Lederman MM, Huang Y, Tracy RP, Cao H, Haberer JE, Kembabazi A, Bangsberg DR, Martin JN, Hunt PW. Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy. J Infect Dis. 2017 04 15; 215(8):1270-1274. PMID: 28329310.
      Citations: 14     Fields:    Translation:HumansCells
    49. Ayakaka I, Ackerman S, Ggita JM, Kajubi P, Dowdy D, Haberer JE, Fair E, Hopewell P, Handley MA, Cattamanchi A, Katamba A, Davis JL. Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach. Implement Sci. 2017 03 09; 12(1):33. PMID: 28274245.
      Citations: 28     Fields:    Translation:Humans
    50. Georgette N, Siedner MJ, Petty CR, Zanoni BC, Carpenter S, Haberer JE. Impact of a clinical program using weekly Short Message Service (SMS) on antiretroviral therapy adherence support in South Africa: a retrospective cohort study. BMC Med Inform Decis Mak. 2017 Feb 20; 17(1):18. PMID: 28219372.
      Citations: 9     Fields:    Translation:Humans
    51. Atukunda EC, Musiimenta A, Musinguzi N, Wyatt MA, Ashaba J, Ware NC, Haberer JE. Understanding Patterns of Social Support and Their Relationship to an ART Adherence Intervention Among Adults in Rural Southwestern Uganda. AIDS Behav. 2017 Feb; 21(2):428-440. PMID: 27671479.
      Citations: 17     Fields:    Translation:Humans
    52. Haberer JE, Musinguzi N, Tsai AC, Boum Y, Bwana BM, Muzoora C, Hunt PW, Martin JN, Bangsberg DR. Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring. AIDS. 2017 01 02; 31(1):169-171. PMID: 27835622.
      Citations: 14     Fields:    Translation:Humans
    53. Morton JF, Celum C, Njoroge J, Nakyanzi A, Wakhungu I, Tindimwebwa E, Ongachi S, Sedah E, Okwero E, Ngure K, Odoyo J, Bulya N, Haberer JE, Baeten JM, Heffron R. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention. J Acquir Immune Defic Syndr. 2017 01 01; 74 Suppl 1:S15-S22. PMID: 27930607.
      Citations: 22     Translation:HumansPHPublic Health
    54. Madrasi K, Chaturvedula A, Haberer JE, Sale M, Fossler MJ, Bangsberg D, Baeten JM, Celum C, Hendrix CW. Markov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis. J Clin Pharmacol. 2017 05; 57(5):606-615. PMID: 27922719.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    55. Okello S, Asiimwe SB, Kanyesigye M, Muyindike WR, Boum Y, Mwebesa BB, Haberer JE, Huang Y, Williams K, Burdo TH, Tracy RP, Bangsberg DR, Mocello AR, Martin JN, Hunt PW, Siedner MJ. D-Dimer Levels and Traditional Risk Factors Are Associated With Incident Hypertension Among HIV-Infected Individuals Initiating Antiretroviral Therapy in Uganda. J Acquir Immune Defic Syndr. 2016 Dec 01; 73(4):396-402. PMID: 27171743.
      Citations: 10     Translation:Humans
    56. Haberer JE. Actionable adherence monitoring to optimise intervention. Lancet HIV. 2017 01; 4(1):e5-e6. PMID: 27864001.
      Citations: 8     Fields:    Translation:Humans
    57. Musinguzi N, Muwonge T, Thomas K, Baeten JM, Bangsberg DR, Haberer JE. Does Adherence Change When No One is Looking? Comparing Announced and Unannounced Tenofovir Levels in a PrEP Trial. AIDS Behav. 2016 11; 20(11):2639-2643. PMID: 26781865.
      Citations: 3     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    58. Georgette N, Siedner MJ, Zanoni B, Sibaya T, Petty CR, Carpenter S, Haberer JE. The Acceptability and Perceived Usefulness of a Weekly Clinical SMS Program to Promote HIV Antiretroviral Medication Adherence in KwaZulu-Natal, South Africa. AIDS Behav. 2016 11; 20(11):2629-2638. PMID: 26781866.
      Citations: 19     Fields:    Translation:Humans
    59. Zanoni BC, Archary M, Buchan S, Katz IT, Haberer JE. Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the Cresting Wave. BMJ Glob Health. 2016; 1(3):e000004. PMID: 28588949.
      Citations: 41     
    60. Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, Asiimwe S, Haberer JE, Morton J, Ngure K, Bulya N, Odoyo J, Tindimwebwa E, Hendrix C, Marzinke MA, Ware NC, Wyatt MA, Morrison S, Haugen H, Mujugira A, Donnell D, Celum C. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda. PLoS Med. 2016 08; 13(8):e1002099. PMID: 27552090.
      Citations: 85     Fields:    Translation:HumansCellsPHPublic Health
    61. Lu Y, Goti V, Chaturvedula A, Haberer JE, Fossler MJ, Sale ME, Bangsberg D, Baeten JM, Celum CL, Hendrix CW. Population Pharmacokinetics of Tenofovir in HIV-1-Uninfected Members of Serodiscordant Couples and Effect of Dose Reporting Methods. Antimicrob Agents Chemother. 2016 09; 60(9):5379-86. PMID: 27353269.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    62. Haberer JE, Musiimenta A, Atukunda EC, Musinguzi N, Wyatt MA, Ware NC, Bangsberg DR. Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS. 2016 05 15; 30(8):1295-300. PMID: 26760452.
      Citations: 57     Fields:    Translation:Humans
    63. Musinguzi N, Muganzi CD, Boum Y, Ronald A, Marzinke MA, Hendrix CW, Celum C, Baeten JM, Bangsberg DR, Haberer JE. Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa. AIDS. 2016 Apr 24; 30(7):1121-9. PMID: 26785125.
      Citations: 20     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    64. Matthews LT, Ribaudo HB, Kaida A, Bennett K, Musinguzi N, Siedner MJ, Kabakyenga J, Hunt PW, Martin JN, Boum Y, Haberer JE, Bangsberg DR. HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods. J Acquir Immune Defic Syndr. 2016 Apr 01; 71(4):399-406. PMID: 26495883.
      Citations: 14     Translation:HumansCells
    65. Siedner MJ, Kim JH, Nakku RS, Hemphill L, Triant VA, Haberer JE, Martin JN, Boum Y, Kwon DS, Tsai AC, Hunt PW, Okello S, Bangsberg DR. HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda. AIDS. 2016 Feb 20; 30(4):667-70. PMID: 26636926.
      Citations: 15     Fields:    Translation:Humans
    66. Haberer JE. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice. Curr Opin HIV AIDS. 2016 Jan; 11(1):10-7. PMID: 26633638.
      Citations: 68     Fields:    Translation:HumansPHPublic Health
    67. Campbell JI, Haberer JE. Cell Phone-Based and Adherence Device Technologies for HIV Care and Treatment in Resource-Limited Settings: Recent Advances. Curr HIV/AIDS Rep. 2015 Dec; 12(4):523-31. PMID: 26439917.
      Citations: 13     Fields:    Translation:Humans
    68. Haberer JE, Musinguzi N, Boum Y, Siedner MJ, Mocello AR, Hunt PW, Martin JN, Bangsberg DR. Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda. J Acquir Immune Defic Syndr. 2015 Dec 01; 70(4):386-92. PMID: 26110445.
      Citations: 34     Translation:Humans
    69. Campbell JI, Eyal N, Musiimenta A, Haberer JE. Ethical Questions in Medical Electronic Adherence Monitoring. J Gen Intern Med. 2016 Mar; 31(3):338-42. PMID: 26358284.
      Citations: 20     Fields:    Translation:Humans
    70. Siedner MJ, Kim JH, Nakku RS, Bibangambah P, Hemphill L, Triant VA, Haberer JE, Martin JN, Mocello AR, Boum Y, Kwon DS, Tracy RP, Burdo T, Huang Y, Cao H, Okello S, Bangsberg DR, Hunt PW. Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy. J Infect Dis. 2016 Feb 01; 213(3):370-8. PMID: 26347573.
      Citations: 42     Fields:    Translation:Humans
    71. Sabin LL, Bachman DeSilva M, Gill CJ, Zhong L, Vian T, Xie W, Cheng F, Xu K, Lan G, Haberer JE, Bangsberg DR, Li Y, Lu H, Gifford AL. Improving Adherence to Antiretroviral Therapy With Triggered Real-time Text Message Reminders: The China Adherence Through Technology Study. J Acquir Immune Defic Syndr. 2015 Aug 15; 69(5):551-9. PMID: 25886927.
      Citations: 60     Translation:Humans
    72. Haberer JE, Bangsberg DR, Baeten JM, Curran K, Koechlin F, Amico KR, Anderson P, Mugo N, Venter F, Goicochea P, Caceres C, O'Reilly K. Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. AIDS. 2015 Jul 17; 29(11):1277-85. PMID: 26103095.
      Citations: 99     Fields:    Translation:HumansPHPublic Health
    73. Siedner MJ, Santorino D, Lankowski AJ, Kanyesigye M, Bwana MB, Haberer JE, Bangsberg DR. A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda: a prospective observational cohort study. BMC Med. 2015 Jul 06; 13:160. PMID: 26149722.
      Citations: 29     Fields:    Translation:HumansCTClinical Trials
    74. Nieves CI, Kaida A, Seage GR, Kabakyenga J, Muyindike W, Boum Y, Mocello AR, Martin JN, Hunt PW, Haberer JE, Bangsberg DR, Matthews LT. The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda. Contraception. 2015 Aug; 92(2):152-9. PMID: 25983013.
      Citations: 10     Fields:    Translation:Humans
    75. Mugo PM, Sanders EJ, Mutua G, van der Elst E, Anzala O, Barin B, Bangsberg DR, Priddy FH, Haberer JE. Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya. AIDS Behav. 2015 May; 19(5):794-801. PMID: 25432877.
      Citations: 17     Fields:    Translation:HumansPHPublic Health
    76. Kintu A, Hankinson SE, Balasubramanian R, Ertel K, Tumwesigye E, Bangsberg DR, Haberer JE. Sexual Relationships Outside Primary Partnerships and Abstinence Are Associated With Lower Adherence and Adherence Gaps: Data From the Partners PrEP Ancillary Adherence Study. J Acquir Immune Defic Syndr. 2015 May 01; 69(1):36-43. PMID: 25942457.
      Citations:    Translation:HumansPHPublic HealthCTClinical Trials
    77. Petersen ML, LeDell E, Schwab J, Sarovar V, Gross R, Reynolds N, Haberer JE, Goggin K, Golin C, Arnsten J, Rosen MI, Remien RH, Etoori D, Wilson IB, Simoni JM, Erlen JA, van der Laan MJ, Liu H, Bangsberg DR. Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring. J Acquir Immune Defic Syndr. 2015 May 01; 69(1):109-18. PMID: 25942462.
      Citations: 19     Translation:Humans
    78. Kreitchmann R, Coelho DF, Kakehasi FM, Hofer CB, Read JS, Losso M, Haberer JE, Siberry GK, Harris DR, Yu Q. Long-term postpartum adherence to antiretroviral drugs among women in Latin America. Int J STD AIDS. 2016 Apr; 27(5):377-86. PMID: 25931238.
      Citations: 3     Fields:    Translation:Humans
    79. Olds PK, Kiwanuka JP, Ware NC, Tsai AC, Haberer JE. Explaining antiretroviral therapy adherence success among HIV-infected children in rural Uganda: a qualitative study. AIDS Behav. 2015 Apr; 19(4):584-93. PMID: 25323679.
      Citations: 8     Fields:    Translation:Humans
    80. Chan BT, Weiser SD, Boum Y, Siedner MJ, Mocello AR, Haberer JE, Hunt PW, Martin JN, Mayer KH, Bangsberg DR, Tsai AC. Persistent HIV-related stigma in rural Uganda during a period of increasing HIV incidence despite treatment expansion. AIDS. 2015 Jan 02; 29(1):83-90. PMID: 25268886.
      Citations: 28     Fields:    Translation:Humans
    81. Psaros C, Haberer JE, Boum Y, Tsai AC, Martin JN, Hunt PW, Bangsberg DR, Safren SA. The factor structure and presentation of depression among HIV-positive adults in Uganda. AIDS Behav. 2015 Jan; 19(1):27-33. PMID: 24854877.
      Citations: 16     Fields:    Translation:Humans
    82. Chan BT, Weiser SD, Boum Y, Haberer JE, Kembabazi A, Hunt PW, Martin JN, Mocello AR, Bangsberg DR, Tsai AC. Declining prevalence of probable depression among patients presenting for antiretroviral therapy in rural Uganda: the role of early treatment initiation. AIDS Behav. 2015 Jan; 19(1):19-26. PMID: 24788780.
      Citations: 5     Fields:    Translation:Humans
    83. Baxi SM, Liu A, Bacchetti P, Mutua G, Sanders EJ, Kibengo FM, Haberer JE, Rooney J, Hendrix CW, Anderson PL, Huang Y, Priddy F, Gandhi M. Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures. J Acquir Immune Defic Syndr. 2015 Jan 01; 68(1):13-20. PMID: 25296098.
      Citations: 42     Fields:    Translation:HumansPHPublic Health
    84. Olds PK, Kiwanuka JP, Nansera D, Huang Y, Bacchetti P, Jin C, Gandhi M, Haberer JE. Assessment of HIV antiretroviral therapy adherence by measuring drug concentrations in hair among children in rural Uganda. AIDS Care. 2015; 27(3):327-32. PMID: 25483955.
      Citations: 21     Fields:    Translation:Humans
    85. Kaida A, Matthews LT, Ashaba S, Tsai AC, Kanters S, Robak M, Psaros C, Kabakyenga J, Boum Y, Haberer JE, Martin JN, Hunt PW, Bangsberg DR. Depression during pregnancy and the postpartum among HIV-infected women on antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr. 2014 Dec 01; 67 Suppl 4:S179-87. PMID: 25436816.
      Citations: 29     Translation:Humans
    86. Bajunirwe F, Haberer JE, Boum Y, Hunt P, Mocello R, Martin JN, Bangsberg DR, Hahn JA. Comparison of self-reported alcohol consumption to phosphatidylethanol measurement among HIV-infected patients initiating antiretroviral treatment in southwestern Uganda. PLoS One. 2014; 9(12):e113152. PMID: 25436894.
      Citations: 47     Fields:    Translation:Humans
    87. Atwiine B, Kiwanuka J, Musinguzi N, Atwine D, Haberer JE. Understanding the role of age in HIV disclosure rates and patterns for HIV-infected children in southwestern Uganda. AIDS Care. 2015; 27(4):424-30. PMID: 25397994.
      Citations: 14     Fields:    Translation:Humans
    88. Baeten JM, Donnell D, Mugo NR, Ndase P, Thomas KK, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kidoguchi L, Coombs RW, Hendrix C, Marzinke MA, Frenkel L, Haberer JE, Bangsberg D, Celum C. Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial. Lancet Infect Dis. 2014 Nov; 14(11):1055-1064. PMID: 25300863.
      Citations: 55     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    89. Psaros C, Haberer JE, Katabira E, Ronald A, Tumwesigye E, Campbell JD, Wangisi J, Mugwanya K, Kintu A, Enyakoit M, Thomas KK, Donnell D, Krows M, Kidoguchi L, Ware N, Baeten JM, Celum C, Bangsberg DR, Safren SA. An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda. J Acquir Immune Defic Syndr. 2014 Aug 15; 66(5):522-9. PMID: 24853311.
      Citations: 29     Fields:    Translation:Humans
    90. Lankowski AJ, Tsai AC, Kanyesigye M, Bwana M, Haberer JE, Wenger M, Martin JN, Bangsberg DR, Hunt PW, Siedner MJ. Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy. PLoS Negl Trop Dis. 2014 Aug; 8(8):e3036. PMID: 25101890.
      Citations: 6     Fields:    Translation:Humans
    91. Takada S, Weiser SD, Kumbakumba E, Muzoora C, Martin JN, Hunt PW, Haberer JE, Kawuma A, Bangsberg DR, Tsai AC. The dynamic relationship between social support and HIV-related stigma in rural Uganda. Ann Behav Med. 2014 Aug; 48(1):26-37. PMID: 24500077.
      Citations: 35     Fields:    Translation:Humans
    92. McMahon JM, Myers JE, Kurth AE, Cohen SE, Mannheimer SB, Simmons J, Pouget ER, Trabold N, Haberer JE. Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges. AIDS Patient Care STDS. 2014 Sep; 28(9):462-74. PMID: 25045996.
      Citations: 38     Fields:    Translation:HumansPHPublic Health
    93. Donnell D, Baeten JM, Bumpus NN, Brantley J, Bangsberg DR, Haberer JE, Mujugira A, Mugo N, Ndase P, Hendrix C, Celum C. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr. 2014 Jul 01; 66(3):340-8. PMID: 24784763.
      Citations: 144     Fields:    Translation:HumansCTClinical Trials
    94. Kruse GR, Bangsberg DR, Hahn JA, Haberer JE, Hunt PW, Muzoora C, Bennett JP, Martin JN, Rigotti NA. Tobacco use among adults initiating treatment for HIV infection in rural Uganda. AIDS Behav. 2014 Jul; 18(7):1381-9. PMID: 24638166.
      Citations: 8     Fields:    Translation:Humans
    95. Venkataramani AS, Thirumurthy H, Haberer JE, Ii YB, Siedner MJ, Kembabazi A, Hunt PW, Martin JN, Bangsberg DR, Tsai AC. CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda. AIDS. 2014 May 15; 28(8):1221-6. PMID: 24406678.
      Citations: 14     Fields:    Translation:Humans
    96. Machtinger EL, Lavin SM, Hilliard S, Jones R, Haberer JE, Capito K, Dawson-Rose C. An expressive therapy group disclosure intervention for women living with HIV improves social support, self-efficacy, and the safety and quality of relationships: a qualitative analysis. J Assoc Nurses AIDS Care. 2015 Mar-Apr; 26(2):187-98. PMID: 25027284.
      Citations: 4     Fields:    Translation:Humans
    97. Martinez P, Tsai AC, Muzoora C, Kembabazi A, Weiser SD, Huang Y, Haberer JE, Martin JN, Bangsberg DR, Hunt PW. Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans. J Acquir Immune Defic Syndr. 2014 Apr 01; 65(4):456-62. PMID: 24220289.
      Citations: 45     Fields:    Translation:Humans
    98. Kiwanuka J, Mulogo E, Haberer JE. Caregiver perceptions and motivation for disclosing or concealing the diagnosis of HIV infection to children receiving HIV care in Mbarara, Uganda: a qualitative study. PLoS One. 2014; 9(3):e93276. PMID: 24667407.
      Citations: 25     Fields:    Translation:Humans
    99. Byakwaga H, Boum Y, Huang Y, Muzoora C, Kembabazi A, Weiser SD, Bennett J, Cao H, Haberer JE, Deeks SG, Bangsberg DR, McCune JM, Martin JN, Hunt PW. The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy. J Infect Dis. 2014 Aug 01; 210(3):383-91. PMID: 24585899.
      Citations: 58     Fields:    Translation:HumansCells
    100. Siedner MJ, Musinguzi N, Tsai AC, Muzoora C, Kembabazi A, Weiser SD, Bennett J, Hunt PW, Martin JN, Haberer JE, Bangsberg DR. Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda. AIDS. 2014 Jan 14; 28(2):267-71. PMID: 24361683.
      Citations: 9     Fields:    Translation:Humans
    101. Tsai AC, Bangsberg DR, Kegeles SM, Katz IT, Haberer JE, Muzoora C, Kumbakumba E, Hunt PW, Martin JN, Weiser SD. Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med. 2013 Dec; 46(3):285-94. PMID: 23690283.
      Citations: 68     Fields:    Translation:Humans
    102. Matthews LT, Kaida A, Kanters S, Byakwagamd H, Mocello AR, Muzoora C, Kembabazi A, Haberer JE, Martin JN, Bangsberg DR, Hunt PW. HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods. AIDS. 2013 Oct; 27 Suppl 1:S105-12. PMID: 24088676.
      Citations: 14     Fields:    Translation:HumansCells
    103. Tsai AC, Bangsberg DR, Bwana M, Haberer JE, Frongillo EA, Muzoora C, Kumbakumba E, Hunt PW, Martin JN, Weiser SD. How does antiretroviral treatment attenuate the stigma of HIV? Evidence from a cohort study in rural Uganda. AIDS Behav. 2013 Oct; 17(8):2725-31. PMID: 23670710.
      Citations: 37     Fields:    Translation:Humans
    104. Kibengo FM, Ruzagira E, Katende D, Bwanika AN, Bahemuka U, Haberer JE, Bangsberg DR, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Kamali A, Priddy FH. Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial. PLoS One. 2013; 8(9):e74314. PMID: 24086333.
      Citations: 46     Fields:    Translation:Humans
    105. Haberer JE, Baeten JM, Campbell J, Wangisi J, Katabira E, Ronald A, Tumwesigye E, Psaros C, Safren SA, Ware NC, Thomas KK, Donnell D, Krows M, Kidoguchi L, Celum C, Bangsberg DR. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. PLoS Med. 2013; 10(9):e1001511. PMID: 24058300.
      Citations: 106     Fields:    Translation:Humans
    106. Haberer JE, Kiwanuka J, Nansera D, Muzoora C, Hunt PW, So J, O'Donnell M, Siedner M, Martin JN, Bangsberg DR. Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda. AIDS. 2013 Aug 24; 27(13):2166-8. PMID: 23751260.
      Citations: 33     Fields:    Translation:HumansCells
    107. Kembabazi A, Bajunirwe F, Hunt PW, Martin JN, Muzoora C, Haberer JE, Bangsberg DR, Siedner MJ. Disinhibition in risky sexual behavior in men, but not women, during four years of antiretroviral therapy in rural, southwestern Uganda. PLoS One. 2013; 8(7):e69634. PMID: 23894514.
      Citations: 10     Fields:    Translation:Humans
    108. Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV prevention: where have we been and where are we going? J Acquir Immune Defic Syndr. 2013 Jul; 63 Suppl 2:S122-9. PMID: 23764623.
      Citations: 79     Fields:    Translation:Humans
    109. Siedner MJ, Lankowski A, Tsai AC, Muzoora C, Martin JN, Hunt PW, Haberer JE, Bangsberg DR. GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda. AIDS. 2013 Jun 01; 27(9):1503-8. PMID: 23435294.
      Citations: 51     Fields:    Translation:Humans
    110. Chaiyachati KH, Loveday M, Lorenz S, Lesh N, Larkan LM, Cinti S, Friedland GH, Haberer JE. A pilot study of an mHealth application for healthcare workers: poor uptake despite high reported acceptability at a rural South African community-based MDR-TB treatment program. PLoS One. 2013; 8(5):e64662. PMID: 23724075.
      Citations: 42     Fields:    Translation:Humans
    111. Hofer CB, Harris DR, Saavedra MC, Haberer JE, Romeiro J, Mussi-Pinhata MM, Stankievich E, Gomes IM, Kreitchmann R, Read JS. Adherence to antiretroviral prophylaxis during early infancy in Latin America. Braz J Infect Dis. 2013 Jul-Aug; 17(4):495-6. PMID: 23680065.
      Citations:    Fields:    Translation:Humans
    112. Haberer JE, Trabin T, Klinkman M. Furthering the reliable and valid measurement of mental health screening, diagnoses, treatment and outcomes through health information technology. Gen Hosp Psychiatry. 2013 Jul-Aug; 35(4):349-53. PMID: 23628162.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    113. Baylor A, Muzoora C, Bwana M, Kembabazi A, Haberer JE, Matthews LT, Tsai AC, Hunt PW, Martin JN, Bangsberg DR. Dissemination of research findings to research participants living with HIV in rural Uganda: challenges and rewards. PLoS Med. 2013; 10(3):e1001397. PMID: 23472055.
      Citations: 10     Fields:    Translation:Humans
    114. Adakun SA, Siedner MJ, Muzoora C, Haberer JE, Tsai AC, Hunt PW, Martin JN, Bangsberg DR. Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda. J Acquir Immune Defic Syndr. 2013 Mar 01; 62(3):317-21. PMID: 23242160.
      Citations: 30     Fields:    Translation:Humans
    115. Bangsberg DR, Haberer JE. Lifetime HIV antiretroviral therapy adherence intervention: timing is everything: comment on "Managed problem solving for antiretroviral therapy adherence". JAMA Intern Med. 2013 Feb 25; 173(4):306-7. PMID: 23358810.
      Citations: 4     Fields:    Translation:HumansCells
    116. Horwitz RH, Tsai AC, Maling S, Bajunirwe F, Haberer JE, Emenyonu N, Muzoora C, Hunt PW, Martin JN, Bangsberg DR. No association found between traditional healer use and delayed antiretroviral initiation in rural Uganda. AIDS Behav. 2013 Jan; 17(1):260-5. PMID: 22246516.
      Citations: 7     Fields:    Translation:Humans
    117. Siedner MJ, Lankowski A, Musinga D, Jackson J, Muzoora C, Hunt PW, Martin JN, Bangsberg DR, Haberer JE. Optimizing network connectivity for mobile health technologies in sub-Saharan Africa. PLoS One. 2012; 7(9):e45643. PMID: 23029155.
      Citations: 13     Fields:    Translation:Humans
    118. Siedner MJ, Tsai AC, Dworkin S, Mukiibi NF, Emenyonu NI, Hunt PW, Haberer JE, Martin JN, Bangsberg DR, Weiser SD. Sexual relationship power and malnutrition among HIV-positive women in rural Uganda. AIDS Behav. 2012 Aug; 16(6):1542-8. PMID: 22382629.
      Citations: 9     Fields:    Translation:Humans
    119. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kakia A, Odoyo J, Mucunguzi A, Nakku-Joloba E, Twesigye R, Ngure K, Apaka C, Tamooh H, Gabona F, Mujugira A, Panteleeff D, Thomas KK, Kidoguchi L, Krows M, Revall J, Morrison S, Haugen H, Emmanuel-Ogier M, Ondrejcek L, Coombs RW, Frenkel L, Hendrix C, Bumpus NN, Bangsberg D, Haberer JE, Stevens WS, Lingappa JR, Celum C. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012 Aug 02; 367(5):399-410. PMID: 22784037.
      Citations: 1363     Fields:    Translation:HumansCellsCTClinical Trials
    120. Siedner MJ, Lankowski A, Haberer JE, Kembabazi A, Emenyonu N, Tsai AC, Muzoora C, Geng E, Martin JN, Bangsberg DR. Rethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS One. 2012; 7(6):e39894. PMID: 22761924.
      Citations: 32     Fields:    Translation:Humans
    121. Siedner MJ, Haberer JE, Bwana MB, Ware NC, Bangsberg DR. High acceptability for cell phone text messages to improve communication of laboratory results with HIV-infected patients in rural Uganda: a cross-sectional survey study. BMC Med Inform Decis Mak. 2012 Jun 21; 12:56. PMID: 22720901.
      Citations: 46     Fields:    Translation:Humans
    122. Kreitchmann R, Harris DR, Kakehasi F, Haberer JE, Cahn P, Losso M, Teles E, Pilotto JH, Hofer CB, Read JS. Antiretroviral adherence during pregnancy and postpartum in Latin America. AIDS Patient Care STDS. 2012 Aug; 26(8):486-95. PMID: 22663185.
      Citations: 19     Fields:    Translation:Humans
    123. Haberer JE, Kiwanuka J, Nansera D, Ragland K, Mellins C, Bangsberg DR. Multiple measures reveal antiretroviral adherence successes and challenges in HIV-infected Ugandan children. PLoS One. 2012; 7(5):e36737. PMID: 22590600.
      Citations: 29     Fields:    Translation:HumansCellsCTClinical Trials
    124. van der Straten A, Van Damme L, Haberer JE, Bangsberg DR. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS. 2012 Apr 24; 26(7):F13-9. PMID: 22333749.
      Citations: 169     Fields:    Translation:HumansCells
    125. Ware NC, Wyatt MA, Haberer JE, Baeten JM, Kintu A, Psaros C, Safren S, Tumwesigye E, Celum CL, Bangsberg DR. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples. J Acquir Immune Defic Syndr. 2012 Apr 15; 59(5):463-8. PMID: 22267018.
      Citations: 146     Fields:    Translation:HumansCTClinical Trials
    126. Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Priddy FH. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. PLoS One. 2012; 7(4):e33103. PMID: 22511916.
      Citations: 77     Fields:    Translation:HumansCells
    127. Haberer JE, Robbins GK, Ybarra M, Monk A, Ragland K, Weiser SD, Johnson MO, Bangsberg DR. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav. 2012 Feb; 16(2):375-82. PMID: 21448728.
      Citations: 35     Fields:    Translation:Humans
    128. Haberer JE, Cook A, Walker AS, Ngambi M, Ferrier A, Mulenga V, Kityo C, Thomason M, Kabamba D, Chintu C, Gibb DM, Bangsberg DR. Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects. PLoS One. 2011 Apr 21; 6(4):e18505. PMID: 21533031.
      Citations: 50     Fields:    Translation:Humans
    129. Haberer JE, Kahane J, Kigozi I, Emenyonu N, Hunt P, Martin J, Bangsberg DR. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010 Dec; 14(6):1340-6. PMID: 20809380.
      Citations: 107     Fields:    Translation:Humans
    130. Haberer JE, Kiwanuka J, Nansera D, Wilson IB, Bangsberg DR. Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting. AIDS Behav. 2010 Dec; 14(6):1294-301. PMID: 20532605.
      Citations: 67     Fields:    Translation:Humans
    131. Katz IT, Ware NC, Gray G, Haberer JE, Mellins CA, Bangsberg DR. Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence. Sex Health. 2010 Sep; 7(3):279-86. PMID: 20719215.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    132. Zhang F, Haberer JE, Zhao Y, Dou Z, Zhao H, He Y, Cao GH. Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomes. J Acquir Immune Defic Syndr. 2007 Dec 15; 46(5):594-8. PMID: 18043313.
      Citations: 14     Translation:Humans
    133. Zhang F, Haberer JE, Wang Y, Zhao Y, Ma Y, Zhao D, Yu L, Goosby EP. The Chinese free antiretroviral treatment program: challenges and responses. AIDS. 2007 Dec; 21 Suppl 8:S143-8. PMID: 18172383.
      Citations: 85     Fields:    Translation:HumansPHPublic Health
    134. Haberer JE, Garrett B, Baker LC. Does Medicaid managed care affect access to care for the uninsured? Health Aff (Millwood). 2005 Jul-Aug; 24(4):1095-105. PMID: 16012150.
      Citations: 2     Fields:    Translation:Humans
    135. Haberer JE, Ix JH, Tierney LM. Clinical problem-solving. One foot away. N Engl J Med. 2002 May 02; 346(18):1394-7. PMID: 11986414.
      Citations: 1     Fields:    Translation:HumansCells